| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | ||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross margin | 237,9 k € | +25.9% | 188,9 k € | -42.4% | 327,8 k € | +64.7% | 199,0 k € | -24.2% | 262,7 k € | +25.9% | 208,7 k € | -14.6% | 244,5 k € | +7.3% | 227,9 k € | +24.5% | 183,1 k € | -7.9% | 198,8 k € | +30.0% | 152,9 k € | -6.0% | 162,7 k € | +6.0% | 153,5 k € | +2.6% | 149,6 k € | +12.2% | 133,4 k € | +17.6% | 113,4 k € | -15.1% | 133,6 k € | +12.3% | 118,9 k € | -35.0% | 183,0 k € | |
| EBITDA | 30,1 k € | +1150.8% | -2,9 k € | -101.9% | 150,8 k € | +287.6% | 38,9 k € | -63.8% | 107,3 k € | +119.7% | 48,9 k € | -17.3% | 59,1 k € | +9.7% | 53,8 k € | +247.5% | 15,5 k € | -69.8% | 51,2 k € | +333.0% | 11,8 k € | +17.4% | 10,1 k € | +31.9% | 7,6 k € | -57.5% | 18,0 k € | +27.1% | 14,1 k € | +8.2% | 13,1 k € | -64.4% | 36,7 k € | +25.1% | 29,3 k € | -63.8% | 81,0 k € | |
| Operating profit | 28,4 k € | +437.4% | -8,4 k € | -105.9% | 143,6 k € | +427.8% | 27,2 k € | -71.2% | 94,5 k € | +154.4% | 37,1 k € | -25.7% | 50,0 k € | +4.7% | 47,7 k € | +278.2% | 12,6 k € | -73.8% | 48,1 k € | +473.5% | 8,4 k € | +17.9% | 7,1 k € | +180.9% | 2,5 k € | -80.6% | 13,0 k € | +35.9% | 9,6 k € | -11.5% | 10,8 k € | -56.4% | 24,9 k € | +59.6% | 15,6 k € | -77.3% | 68,8 k € | |
| Profit/loss | 20,9 k € | +250.9% | -13,9 k € | +94.1% | -234,0 k € | -2771.0% | 8,8 k € | -85.2% | 59,1 k € | +255.1% | 16,6 k € | -17.2% | 20,1 k € | -5.4% | 21,2 k € | +1124.5% | -2,1 k € | -409.1% | 670,1 € | +139.5% | -1,7 k € | +45.5% | -3,1 k € | +44.5% | -5,6 k € | -536.3% | 1,3 k € | +1241.6% | -112,7 € | -112.5% | 898,9 € | +536.2% | -206,1 € | -104.6% | 4,5 k € | -89.9% | 43,9 k € | |
| Equity | 15,7 k € | +398.3% | -5,3 k € | -161.0% | 8,6 k € | -96.6% | 253,1 k € | +0.9% | 250,9 k € | +26.4% | 198,5 k € | +14.4% | 173,4 k € | +25.6% | 138,1 k € | +18.2% | 116,9 k € | -1.7% | 119,0 k € | +0.6% | 118,3 k € | -1.4% | 120,0 k € | -2.5% | 123,1 k € | -4.4% | 128,7 k € | +1.0% | 127,4 k € | -0.1% | 127,5 k € | +0.7% | 126,6 k € | -0.2% | 126,9 k € | +3.6% | 122,4 k € | |
| Total assets | 272,3 k € | +1.2% | 269,1 k € | -1.2% | 272,3 k € | -52.9% | 578,3 k € | -17.1% | 697,6 k € | +9.3% | 638,1 k € | +0.3% | 636,4 k € | +13.9% | 558,6 k € | +8.7% | 513,9 k € | +11.6% | 460,6 k € | +4.1% | 442,5 k € | +8.4% | 408,4 k € | +2.1% | 399,8 k € | -1.1% | 404,3 k € | +1.5% | 398,3 k € | -3.2% | 411,6 k € | +26.2% | 326,1 k € | +0.2% | 325,4 k € | -27.0% | 446,0 k € | |
| Cash | 56,9 k € | -18.0% | 69,3 k € | -21.2% | 88,0 k € | +96.3% | 44,8 k € | -35.3% | 69,3 k € | +35.2% | 51,3 k € | -15.3% | 60,5 k € | +83.9% | 32,9 k € | +23.0% | 26,7 k € | -1.7% | 27,2 k € | +33.5% | 20,4 k € | +230.6% | 6,2 k € | -62.8% | 16,6 k € | -41.0% | 28,1 k € | +145.3% | 11,4 k € | -54.4% | 25,1 k € | +123.7% | 11,2 k € | +81.9% | 6,2 k € | +7.7% | 5,7 k € | |
| Debts | 210,6 k € | -14.5% | 246,2 k € | +3.9% | 237,1 k € | -11.9% | 269,2 k € | -34.4% | 410,7 k € | +1.8% | 403,6 k € | -5.5% | 427,0 k € | +1.6% | 420,5 k € | +29.3% | 325,1 k € | +4.8% | 310,1 k € | +1.8% | 304,7 k € | +16.4% | 261,7 k € | +2.0% | 256,7 k € | +3.8% | 247,3 k € | +1.4% | 243,8 k € | -14.2% | 284,0 k € | +42.4% | 199,5 k € | +0.4% | 198,6 k € | -38.6% | 323,6 k € | |
| Staff | 4,3 | — | 4 | 3,9 | 3,7 | 4,1 | 4,7 | 4,6 | 4,6 | 4,1 | 4 | 4,6 | 4 | 3,6 | 3,5 | 3,5 | 2,9 | 3 | 3,6 | |||||||||||||||||||
Public limited company · Oostkamp · incorporated on 24/07/2003 · 4,3 ETP
Public limited company profitable and well capitalised. Cash position declining (-18.0%).
Acceptable counterparty for a moderate engagement. Require 2 fiscal years of detailed accounts before any significant exposure. The abridged model hides revenue.
Brussels Medical Center is a Public limited company incorporated in 2003. Its main activity is: Manufacture of pharmaceutical preparations. Its registered office is in Oostkamp. It employs on average 4,3 ETP workers (FTE).
Key indicators
7-day free trial, no credit card required.
7-day free trial, no credit card required.
7-day free trial, no credit card required.
Source: Belgian Official Gazette